Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

Ewen  Cummins; Lorna Sharman Aucott; Clare Robertson; Cynthia Fraser; Rhona Johnston; Thomas Lam; Miriam Giovanna Brazzelli

Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

Ewen Cummins, Lorna Sharman Aucott, Clare Robertson, Cynthia Fraser, Rhona Johnston, Thomas Lam, Miriam Giovanna Brazzelli

Research output: Book/Report › Commissioned Report

Original language	English
Publisher	Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence
Commissioning body	National Institute for Health and Care Excellence
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

https://www.nice.org.uk/guidance/indevelopment/gid-ta10122Licence: Unspecified

Cite this

@book{3ede002c1c584958b6d6e8e2037f403a,

title = "Abiraterone for treating newly diagnosed metastatic hormone-na{\"i}ve prostate cancer.",

author = "Ewen Cummins and Aucott, {Lorna Sharman} and Clare Robertson and Cynthia Fraser and Rhona Johnston and Thomas Lam and Brazzelli, {Miriam Giovanna}",

year = "2018",

language = "English",

publisher = "Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

AU - Cummins, Ewen

AU - Aucott, Lorna Sharman

AU - Robertson, Clare

AU - Fraser, Cynthia

AU - Johnston, Rhona

AU - Lam, Thomas

AU - Brazzelli, Miriam Giovanna

PY - 2018

Y1 - 2018

M3 - Commissioned Report

BT - Abiraterone for treating newly diagnosed metastatic hormone-naïve prostate cancer.

PB - Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care Excellence

ER -